| |
| |
|
| Insider
Information: |
Satter Muneer A |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
60,789,542 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$81,222,382 |
|
|
| Total
Shares |
60,789,542 |
|
|
| Total
Value |
$81,222,382 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 8.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DFC Global Corp |
DLLR |
Director |
|
0 |
2005-01-27 |
1,193,504 |
Premium* |
|
|
HeartWare International Inc |
HTWR |
10% Owner |
2008-04-14 |
0 |
2008-07-11 |
25,150,000 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-03-25 |
0 |
2017-07-05 |
3,037,042 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director, 10% Owner |
|
0 |
2018-09-17 |
0 |
Premium* |
|
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2014-09-22 |
0 |
2014-09-22 |
1,771,688 |
Premium* |
|
|
Aadi Bioscience, Inc |
AADI |
Director, 10% Owner |
2017-03-15 |
0 |
2019-01-10 |
5,621,835 |
Premium* |
|
|
Aileron Therapeutics Inc |
ALRN |
See Remarks, Director |
2017-07-05 |
0 |
2021-01-08 |
16,609,449 |
Premium* |
|
|
Annexon, Inc. |
ANNX |
Director, 10% Owner |
2020-07-28 |
0 |
2023-12-26 |
7,406,024 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DLLR |
DFC Global Corp |
Director |
– • – |
2005-01-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,193,504 |
|
- |
|
| HTWR |
HeartWare International I... |
10% Owner |
– – • |
2008-04-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,750,000 |
|
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2014-04-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
142,117 |
|
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2017-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,835 |
|
- |
|
| ALRN |
Aileron Therapeutics Inc |
10% Owner |
– – • |
2019-04-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,909,449 |
|
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-03-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,441,265 |
1,441,265 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
6,140,402 |
6,282,519 |
0 |
- |
|
| ELDN |
Eledon Pharmaceuticals Or... |
10% Owner |
– – • |
2014-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,621,688 |
1,621,688 |
0 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
144,773 |
144,773 |
0 |
- |
|
| ANNX |
Annexon, Inc. |
Director |
– • – |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,754,978 |
1,754,978 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2018-09-17 |
4 |
S |
$0.29 |
$2,054,257 |
I/I |
(7,044,777) |
0 |
0 |
- |
|
| HTWR |
HeartWare International I... |
10% Owner |
– – • |
2008-04-14 |
4 |
B |
$0.31 |
$314,400 |
I/I |
1,000,000 |
6,000,000 |
1.5 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2018-09-14 |
4 |
S |
$0.36 |
$160,384 |
I/I |
(447,500) |
7,044,777 |
0 |
- |
|
| HTWR |
HeartWare International I... |
10% Owner |
– – • |
2008-07-11 |
4 |
B |
$0.48 |
$2,524,725 |
I/I |
5,250,000 |
150,000 |
1.5 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • • |
2018-09-13 |
4 |
S |
$0.50 |
$1,930,996 |
I/I |
(3,890,000) |
7,492,277 |
0 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
See Remarks |
– • • |
2020-06-08 |
4 |
B |
$1.10 |
$4,070,000 |
I/I |
3,700,000 |
7,609,449 |
2.25 |
% |
|
| ALRN |
Aileron Therapeutics Inc |
See Remarks |
• • – |
2021-01-08 |
4 |
B |
$1.10 |
$9,900,000 |
I/I |
9,000,000 |
16,609,449 |
2.66 |
% |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-27 |
4 |
B |
$1.67 |
$33,410 |
I/I |
20,000 |
5,438,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-26 |
4 |
B |
$1.69 |
$33,854 |
I/I |
20,000 |
5,418,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-28 |
4 |
B |
$1.72 |
$34,372 |
I/I |
20,000 |
5,458,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-31 |
4 |
B |
$1.75 |
$34,900 |
I/I |
20,000 |
5,478,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-21 |
4 |
B |
$1.84 |
$36,870 |
I/I |
20,000 |
5,398,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-20 |
4 |
B |
$1.85 |
$36,984 |
I/I |
20,000 |
5,378,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-12-19 |
4 |
B |
$1.92 |
$38,384 |
I/I |
20,000 |
5,358,017 |
2.25 |
- |
|
| AADI |
Aadi Bioscience, Inc |
Director |
– • • |
2018-11-28 |
4 |
B |
$1.94 |
$38,714 |
I/I |
20,000 |
5,098,017 |
2.25 |
- |
|
91 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
